Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL72538 | 0.97 | — | — | |
| SCHEMBL30686966 | 0.94 | — | — | |
| Ammonia Solution, Strong SCHEMBL20547687 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL3725636 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL6380144 | 0.91 | — | — | |
| SCHEMBL1062238 | 0.88 | — | — | |
| SCHEMBL15310709 | 0.85 | INMT (0.32) | — | |
| SCHEMBL28832759 | 0.75 | GSK3A (0.44) | — | |
| Bicarbonate SCHEMBL29410389 | 0.73 | — | — | |
| SCHEMBL11036759 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2751 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121577878-A | Microorganism label-free rapid detection system, method and application thereof | 福州大学 | 2026-02-27 | — | — | CN | claimed |
| US-20250249020-A1 | COLLOIDALLY STABLE HEME-ALBUMIN COMPLEXES AND METHODS OF MAKING AND USING THEREOF | OHIO STATE INNOVATION FOUNDATION | 2025-08-07 | — | — | US | claimed |
| CN-120058956-A | Bispecific antibody and modified T cell thereof as well as preparation method and application thereof | 首都医科大学附属北京世纪坛医院 | 2025-05-30 | — | — | CN | claimed |
| CN-119780422-A | Alkaline phosphatase antibody marker, preparation method thereof, detection reagent and kit | 深圳市锦瑞生物科技股份有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-117191759-B | Brain glioma boundary identification technology based on Raman spectrum | 中国科学院苏州生物医学工程技术研究所 | 2025-03-28 | — | — | CN | claimed |
| CN-119700817-A | Mitochondrial nano-enzyme complex and preparation method thereof | 南通大学附属医院 | 2025-03-28 | — | — | CN | claimed |
| CN-119613985-A | Composite calcium carbonate powder for rubber and preparation method thereof | 韩城宇星实业有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119564946-A | Azo calixarene-based broad-spectrum quantitative medicine-carrying acupuncture needle, and preparation method and application thereof | 天津中医药大学第一附属医院 | 2025-03-07 | — | — | CN | claimed |
| CN-119530360-A | Use of antibody fragment-enzyme conjugates in high throughput sequencing | 深圳华大智造科技股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-118853528-B | Microbial protein raw material and preparation method thereof | 通辽市海邻生物科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| US-5250702-A | Nonradioactive carriers for radioactive metal elements | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1993-10-05 | — | — | US | claimed |
| EP-0556346-A1 | BIODEGRADABLE PARTICLE COATINGS HAVING A PROTEIN COVALENTLY IMMOBILIZED BY A CROSSLINKING AGENT | COULTER CORPORATION (US) | 1993-08-25 | — | — | EP | claimed |
| US-5169754-A | Colloidal-sized magnetic beads having a crosslinked, adsorbed gelatin coating being functionalized to bind a protein protein, e.g.antibody; immunoassay; cell selection | COULTER CORPORATION (US) | 1992-12-08 | — | — | US | claimed |
| WO-1992008134-A1 | BIODEGRADABLE PARTICLE COATINGS HAVING A PROTEIN COVALENTLY IMMOBILIZED BY A CROSSLINKING AGENT | COULTER CORPORATION (US) | 1992-05-14 | — | — | WO | claimed |
| EP-0214995-B1 | IMMUNOTOXIN AND METHOD OF MAKING | DANA FARBER CANCER INSTITUTE (US) | 1990-12-27 | — | — | EP | claimed |
| US-4888415-A | Gelonin immunotoxin | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1989-12-19 | — | — | US | claimed |
| EP-0214995-A4 | IMMUNOTOXIN AND METHOD OF MAKING. | DANA FARBER CANCER INST INC (US) | 1987-07-22 | — | — | EP | claimed |
| EP-0214995-A1 | IMMUNOTOXIN AND METHOD OF MAKING. | DANA FARBER CANCER INST INC (US) | 1987-03-25 | — | — | EP | claimed |
| WO-1986005098-A1 | IMMUNOTOXIN AND METHOD OF MAKING | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1986-09-12 | — | — | WO | claimed |
| EP-0184710-A2 | Magnetic microspheres | BAYER AG (DE) | 1986-06-18 | — | — | EP | claimed |